Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Sale of 906 ORKA shares, $86.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 906 | $86.7K |
| Sep 1, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 5,000 | $39.0K |
| Jul 1, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 5,000 | $39.0K |
| Jun 15, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 600 | $41.8K |
| May 1, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 5,000 | $39.0K |
| Mar 17, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 600 | $24.8K |
| Mar 2, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 5,000 | $39.0K |
| Jan 23, 2026 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 32,500 | n/a |
| Jan 3, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 5,000 | $39.0K |
| Jul 2, 2025 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 25,000 | n/a |